Related Experiment Video
Updated: Jun 8, 2026
07:03
In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Lipodystrophy: metabolic insights from a rare disorder
Isabel Huang-Doran1, Alison Sleigh, Justin J Rochford
1Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK.
The Journal of Endocrinology
|September 28, 2010
Summary
Rare lipodystrophy patients offer genetic insights into obesity and metabolic syndrome. Studying these extreme fat distribution disorders reveals molecular pathways crucial for adipose tissue function and overall metabolic health.
Area of Science:
- Metabolic disorders
- Human genetics
- Molecular pathogenesis
Background:
- Obesity and insulin resistance are leading causes of morbidity and mortality.
- Understanding the molecular basis of these conditions remains a challenge.
- Extreme phenotypes, such as lipodystrophy, offer valuable models for studying prevalent diseases.
Purpose of the Study:
- To review insights gained from studying rare lipodystrophy syndromes.
- To explore the molecular genetics of lipodystrophy.
- To understand adipose tissue development and its role in metabolic syndrome.
Main Methods:
- Analysis of rare monogenic syndromes with extreme phenotypes.
- Comparative study of patients with excess fat (obesity) and abnormal fat paucity (lipodystrophy).
- Review of existing literature on lipodystrophy and metabolic syndrome.
Main Results:
- Lipodystrophy patients exhibit severe insulin resistance, dyslipidaemia, hepatic steatosis, and hyperandrogenism, mirroring obesity complications.
- Studies of lipodystrophy are yielding insights into the molecular genetics of fat distribution.
- These studies highlight the critical role of adipose tissue function in metabolic health.
Conclusions:
- Rare lipodystrophy syndromes serve as genetically defined models for prevalent metabolic diseases.
- Understanding lipodystrophy advances knowledge of adipose tissue development and function.
- Insights from lipodystrophy research contribute to understanding the metabolic syndrome.
Related Concept Videos
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...